Quest Diagnostics (DGX) Accounts Payables (2016 - 2026)
Quest Diagnostics' Accounts Payables history spans 18 years, with the latest figure at $1.5 billion for Q1 2026.
- On a quarterly basis, Accounts Payables rose 18.39% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 18.39% increase, with the full-year FY2025 number at $1.6 billion, up 14.78% from a year prior.
- Accounts Payables hit $1.5 billion in Q1 2026 for Quest Diagnostics, down from $1.6 billion in the prior quarter.
- Over the last five years, Accounts Payables for DGX hit a ceiling of $1.6 billion in Q4 2025 and a floor of $1.2 billion in Q3 2023.
- Historically, Accounts Payables has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
- Biggest five-year swings in Accounts Payables: decreased 22.41% in 2023 and later rose 18.39% in 2026.
- Tracing DGX's Accounts Payables over 5 years: stood at $1.4 billion in 2022, then decreased by 2.65% to $1.4 billion in 2023, then rose by 2.58% to $1.4 billion in 2024, then grew by 14.78% to $1.6 billion in 2025, then fell by 6.25% to $1.5 billion in 2026.
- Business Quant data shows Accounts Payables for DGX at $1.5 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 billion in Q3 2025.